Loading
Latest filing published 15 Nov 2023 for Apyx Medical Corp, €73k. Read the official filing
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Charles D. Goodwin II is a declared insider of Apyx Medical Corp, with filings sourced from SEC (Form 4). We count 2 filings; the first trade dates from 29 August 2022 and the latest from 14 November 2023.
Every open-market trade on record is a purchase: 2 purchases worth €85k, and no sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Since January 2023: 1 purchase and no sales on the market.
The latest filing, published on 15 November 2023, reports an open-market purchase of €73k in Apyx Medical Corp. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations